Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
Completed · Phase 2
Conditions studied: Inflammation
In brief
This is a multicenter, double-masked, randomized, vehicle-controlled, parallel-comparison study conducted at sites in the United States (US) in subjects undergoing routine unilateral cataract extraction and lens replacement (CELR) surgery via phacoemulsification
Key facts
- Study ID
- NCT06164743
- Run by
- VivaVision Biotech, Inc
- People needed
- 91
- Starts
- 2024-01-11
- Expected to finish
- 2024-05-15
- Last updated by the study team
- 2025-06-10
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥21 years of age and in good general health at Visit 1 (Screening)
- Willing and able to provide informed consent and provide relevant privacy authorization(s)
- Willing and able to comply with study requirements and visit schedule
- Clear ocular media (other than cataract) in the study eye
- Planning to undergo routine unilateral cataract surgery via phacoemulsification extraction and implantation of an intraocular lens.
You may not qualify if…
- Any ocular pain at Visit 1 (Screening)
- Recent use of corticosteroids or oral non-steroidal anti-inflammatory drugs
Where it is running
- United Medical Research Institute — Inglewood, California, United States
- North Bay Eye Associates — Petaluma, California, United States
- Martel Eye Associates — Rancho Cordova, California, United States
- ICON Eye Care — Grand Junction, Colorado, United States
- Levenson Eye Associates — Jacksonville, Florida, United States
- Comprehensive Eye Care, Ltd — Washington, Missouri, United States
- Center For Sight - Las Vegas — Las Vegas, Nevada, United States
- Cincinnati Eye Institute — Cincinnati, Ohio, United States
- Keystone Research — Austin, Texas, United States
- Houston Eye Associates — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.